Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Peter Hänni"'
Autor:
Jannis Müller, Izanne Roos, Tomas Kalincik, Johannes Lorscheider, Edoardo Galli, Pascal Benkert, Sabine Schädelin, Sifat Sharmin, Maximilian Einsiedler, Peter Hänni, Jürg Schmid, Jens Kuhle, Tobias Derfuss, Cristina Granziera, Tjalf Ziemssen, Timo Siepmann, Özgür Yaldizli
Publikováno v:
Brain and Behavior, Vol 14, Iss 5, Pp n/a-n/a (2024)
Abstract Background In patients with relapsing remitting multiple sclerosis (RRMS) on low‐efficacy disease modifying therapies (DMT), the optimal strategy on how to escalate treatment once needed, remains unknown. Methods: We studied RRMS patients
Externí odkaz:
https://doaj.org/article/86d1f84466b94b22a7d83b8760f676f9
Autor:
Johannes Lorscheider, Bernhard F. Décard, Tobias Derfuss, Carmen Lienert, Jens Kuhle, André Moser, Peter Hänni, Pascal Benkert, Ludwig Kappos, Özgür Yaldizli, Viktor von Wyl
Background: Disability progression independent of relapses (PIRA) has been described as a frequent phenomenon in relapsing-remitting multiple sclerosis (RRMS). Objective: To compare the occurrence of disability progression in relapse-free RRMS patien
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ca33fb7d6811a02d53bc25dc00de6ff6
https://doi.org/10.5167/uzh-198005
https://doi.org/10.5167/uzh-198005
Publikováno v:
Frontiers in Conservation Science, Vol 5 (2024)
Many critically endangered species persist in remnant populations so small that ecological information required to assist recovery, such as species-typical demographic parameters and habitat preferences, can be difficult to acquire based on science a
Externí odkaz:
https://doaj.org/article/ca1cbac6150c4fee8f6138f269205f06
Autor:
Özgür Yaldizli, Pascal Benkert, Jens Kuhle, Ludwig Kappos, Peter Hänni, Johannes Lorscheider, Carmen Lienert, Tobias Derfuss
Publikováno v:
Journal of Neurology
Background Dimethyl fumarate and fingolimod are oral disease modifying treatments (DMTs) that reduce relapse activity and slow disability worsening in relapsing–remitting multiple sclerosis (RRMS). Objective To compare the effectiveness of dimethyl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3a1f1cb1b678a1678bf8543b82d0abdc
https://pubmed.ncbi.nlm.nih.gov/32974794
https://pubmed.ncbi.nlm.nih.gov/32974794
Autor:
Peter Hänni
Publikováno v:
medialex.
Derzeit beherrscht das Coronavirus die Schlagzeilen. Weniger gefragt ist Kritik. Mit einigem Recht können die Behörden darauf hinweisen, dass jetzt konkretes Tun gefragt ist und nicht kleinliche Mängelbuchhaltung. Die Grenze zur Behinderung der Ar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::321bcbf4eca72b74122a00d0a9a17dd1
https://doi.org/10.52480/ml.20.12
https://doi.org/10.52480/ml.20.12
Autor:
Bernhard F. Décard, Pascal Benkert, Jens Kuhle, Viktor von Wyl, Ludwig Kappos, Carmen Lienert, Johannes Lorscheider, Peter Hänni, Özgür Yaldizli, Tobias Derfuss
Publikováno v:
European journal of neurologyReferences. 27(6)
Background and purpose To investigate the relation of age at disease onset and clinical outcomes across the lifespan from adolescence in patients with multiple sclerosis (MS) on disease-modifying therapy (DMT). Methods We analysed data from the Swiss
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8822a780f3e79d1970b5ea1916e7adbf
https://pubmed.ncbi.nlm.nih.gov/32097512
https://pubmed.ncbi.nlm.nih.gov/32097512
Autor:
Peter Hänni
Publikováno v:
Revisiting Unity and Diversity in Federal Countries ISBN: 9789004367173
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::faf9b6079800f37ad08ea26334a4e7fe
https://doi.org/10.1163/9789004367180_020
https://doi.org/10.1163/9789004367180_020
Autor:
Pascal Benkert, Özgür Yaldizli, Johannes Lorscheider, Carmen Lienert, Peter Hänni, Tobias Derfuss, Ludwig Kappos, Jens Kuhle
Publikováno v:
Multiple sclerosis (Houndmills, Basingstoke, England). 24(6)
Background: No randomized controlled trials have compared the efficacy of fingolimod or natalizumab as second-line treatment in patients with relapsing–remitting multiple sclerosis (RRMS). Objective: To compare clinical outcomes after escalation to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2440cacaa75f5beaf7e2c711420167b8
https://pubmed.ncbi.nlm.nih.gov/29685060
https://pubmed.ncbi.nlm.nih.gov/29685060
Autor:
Peter Hänni
Publikováno v:
L'Europe en Formation. :111-130
Bien que l’economie suisse soit basee sur le principe de la liberte economique, et bien que l’Etat doive limiter ses interventions sur le marche, il y a des situations dans lesquelles l’Etat est autorise a concurrencer les acteurs prives. C’e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1ee88f36d402a85e3edf95371d6b2813
https://doi.org/10.3917/eufor.358.0111
https://doi.org/10.3917/eufor.358.0111
Publikováno v:
Macromolecules. 37:7285-7289
The swelling behavior of layer-by-layer assemblies of poly(styrenesulfonate) sodium salt (PSS) and poly(allylamine hydrochloride) (PAH) with various number of layers were investigated. The data presented in this paper suggest that swelling and deswel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1e1c980c3098c807cd8c1a8d097c785e
https://doi.org/10.1021/ma0351930
https://doi.org/10.1021/ma0351930